FDA at Turning Point: Kate Rawson Explains

FDA at Turning Point: Kate Rawson Explains

The FDA “is really central, not only to product approvals, but to what [medical product companies] can say in terms of marketing,” Prevision Policy Senior Editor Kate Rawson said at a June 4 CHC webinar...

June 11, 2021 3:42 PM
Read More +

The Real FDA Leadership Story is the New CDER Director, Dr. Patrizia Cavazzoni

The Real FDA Leadership Story is the New CDER Director, Dr. Patrizia Cavazzoni

Despite ongoing speculation about who will be the next FDA Commissioner, “the real leadership story is at CDER,” according to Kate Rawson, senior editor of Prevision Policy...

June 7, 2021 4:11 PM
Read More +

OPDP to Study DTC Multiple Indication Ads, Completes Three Studies in 2020

OPDP to Study DTC Multiple Indication Ads, Completes Three Studies in 2020

The FDA’s Office of Prescription Drug Promotion (OPDP) is preparing to study whether consumers are challenged when multiple indications for the same drug are promoted in a single television ad...

 

May 24, 2021 2:13 PM
Read More +

4A’s Pepper: Data Privacy Issue Is “at an Inflection Point”

4A’s Pepper: Data Privacy Issue Is “at an Inflection Point”

Public concern over the security and privacy of personal data is putting increased pressure on state and federal legislators, and today this issue is “at an inflection point," said Alison Pepper, EVP, Government Relations, at the 4A’s...

May 17, 2021 2:49 PM
Read More +

Recent Posts

Register Now: CHC Webinars Tackle Data Privacy Issues and the Future of the FDA

04, 26, 2021

Read more

Major Health Advertisers Inadvertently Placing Ads on Misinformation Sites

03, 08, 2021

Read more

OPDP Focuses on Misleading Opioid Claims Amid National Crisis

02, 23, 2021

Read more

Upcoming Event

{title}

{body}

Read More +

About Us

CHC

CHC

The Coalition for Healthcare Communication is an organization that promotes the free exchange of scientific and medical information. It is essential that healthcare professionals and the general public receive truthful, accurate information regarding pharmaceuticals, medical products and devices, and patient care.

In addition to white papers and other documents published by the Coalition, you can also find relevant information on current healthcare and health economics issues, as well as policy positions published by government agencies and other professional organizations.